tiprankstipranks
Advertisement
Advertisement
Elicio Therapeutics files $400M mixed securities shelf
PremiumThe FlyElicio Therapeutics files $400M mixed securities shelf
2M ago
Elicio Therapeutics reports inducement grants
Premium
The Fly
Elicio Therapeutics reports inducement grants
2M ago
Elicio Therapeutics reports inducement grants
Premium
The Fly
Elicio Therapeutics reports inducement grants
3M ago
Elicio Therapeutics files to sell 103,225 shares of common stock for holders
PremiumThe FlyElicio Therapeutics files to sell 103,225 shares of common stock for holders
5M ago
Elicio Therapeutics announces additional data from Phase 2 AMPLIFY-7P trial
Premium
The Fly
Elicio Therapeutics announces additional data from Phase 2 AMPLIFY-7P trial
5M ago
Elicio announces preliminary analysis from Phase 2 AMPLIFY-7P trial
Premium
The Fly
Elicio announces preliminary analysis from Phase 2 AMPLIFY-7P trial
6M ago
Elicio Therapeutics Publishes Promising Phase 1 Study Data
PremiumCompany AnnouncementsElicio Therapeutics Publishes Promising Phase 1 Study Data
8M ago
Elicio announces publication of ELI-002 updated AMPLIFY-201 Phase 1 data
Premium
The Fly
Elicio announces publication of ELI-002 updated AMPLIFY-201 Phase 1 data
8M ago
Elicio Therapeutics Reports Q2 2025 Financial Results
Premium
Company Announcements
Elicio Therapeutics Reports Q2 2025 Financial Results
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100